#MWS amyloidosis

[creativeera]

IoT and Virtual Hospital Industry: Global IoT Enabling Next Generation Virtual Hospital

The healthcare industry is embracing new digital technologies at a rapid pace to improve patient outcomes and transform the delivery of care. Internet of Things (IoT) powered solutions are connecting medical devices, integrating telehealth capabilities, and enabling new care models like virtual hospitals that remove geographic barriers. By 2023, IoT healthcare spending is projected to reach $217 billion globally as innovations reshape every aspect of the patient experience from diagnosis to long-term wellness. Connecting Medical Devices with IoT and Virtual Hospital Industry At the core of Global IoT and Virtual Hospital is their ability to remotely monitor patients anytime from anywhere. This relies on medical devices being networked and sensors wirelessly transmitting vital sign data in real-time to the cloud for analysis. IoT is enabling a wide range of devices from blood pressure cuffs and glucose monitors to EKG and pulse oximetry equipment to seamlessly integrate with electronic health records systems. Doctors can easily access streams of patient data via mobile or web applications to track recovery, identify issues early, and proactively adjust care plans as needed from a distance. For example, IoT enabled ventilators allow respiratory therapists to monitor lung function remotely for COPD and asthma patients at high risk of exacerbations. Delivering Telehealth at Scale One of the key benefits of IoT powered virtual hospitals is their ability to provide telehealth services to many more patients across broader geographies. Instead of relying on in-person clinic or hospital visits which can be time-consuming and costly for those in remote areas, IoT infrastructure facilitates real-time video consultations, remote patient monitoring, and live specialist evaluations anytime via mobile or web. This improves access to quality care for underserved communities worldwide. Leading health systems are implementing IoT ecosystems that seamlessly integrate telehealth capabilities like virtual check-ins, remote patient monitoring, and medical device data straight into their telemedicine portals and workflows. The Doximity platform, for example, connects over 560,000 physicians virtually to deliver telehealth at an unmatched scale. Transforming Care Delivery Models IoT is revolutionizing traditional care delivery models through new virtual hospital concepts that reimagine where and how healthcare is provided. Remote patient monitoring is shifting many services like post-acute care, senior care, and chronic disease management to the home. U.S. virtual health provider BestDOT utilizes an IoT platform to enable full service hospitals without physical infrastructure by leveraging connected medical equipment, EHR integrations, telehealth carts and a care coordination system available anywhere. Their virtual hospitals can stand up pop-up clinics or replace facilities damaged by natural disasters, improving both capacity and disaster response. Get more insights on Global IoT and Virtual Hospital

About Author:

Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc. (https://www.linkedin.com/in/money-singh-590844163)

[twinkl22004]

“Muckle-Wells Syndrome”, Victor McKusick, Mendelian Inheritance in Man, 1966.

Here I present: “Muckle-Wells Syndrome”, Victor McKusick, Mendelian Inheritance in Man’, 1966. INTRODUCTION. Muckle–Wells syndrome (MWS) is an autosomal dominant disease which causes sensorineural deafness and recurrent hives and can lead to amyloidosis. Individuals with MWS often have episodic fever, chills, and joint pain. MWS is caused by a defect in the NLRP3 gene (also called CIAS1) which…

[teachingrounds]

Muckle-Wells Syndrome (MWS) is a rare autosomal dominant genetic disorder of IL-1 regulation, thought to be due to a mutation in the gene for the NLRP3 protein. It causes periodic fevers, an urticarial rash, conjunctivitis (>90%) arthralgias (100%), myalgias (50%), chronic fatigue (100%), and sometimes secondary amyloidosis (25%). Typical onset is 70%) go on to develop sensorineural hearing loss in later childhood. MWS is one of the three cryopyrin-associated periodic syndromes (CAPS), the other two being Familial Cold Autoinflammatory Syndrome (FCAS) and some cases of Neonatal-Onset Multisystem Inflammatory Disease (NOMID). Unlike Familial Cold Autoimflammatory Syndrome, triggers for MWS attacks include cold, heat, infection, surgery, and many other other stressors. Treatment includes steroids for acute attacks, NSAIDs + a PPI for joint symptoms, and a chronic IL-1 blocker like anakinra. Clinical Advisor has an excellent article on Muckle-Wells Syndrome, the differential diagnosis, workup, treatment, and counseling for caregivers about side effects and prognosis: http://www.clinicaladvisor.com/pediatrics/muckle-wells-syndrome/article/619834/. #TeachingRounds, #FOAMed, #pediatrics, #peds, #genetics, #raredisease, #immunology

[researchreports2017-blog]

Geographically North America dominated global Muckle-Wells Syndrome market, and Asia Pacific is projected to have fastest growth, owing to extensive R&D activities, technological advancement in research and genetic sciences and growing concern about various genetic disorders. Extensive R&D is one of the major factor, propelling the market growth. Among all the family of cryopyrin, associated periodic syndromes (CAPS) have the highest market share in global Muckle-Wells Syndrome market. This report identifies the global Muckle-Wells Syndrome market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the potential growth opportunities in the coming years, while also reviewing the market drivers, restraints, growth indicators, challenges, market dynamics, competitive landscape, and other key aspects with respect to global Muckle-Wells Syndrome market.Muckle-Wells Syndrome (MWS) is a rare, genetic autosomal disease which leads to urticaria, sensorineural deafness, and also leads to amyloidosis. The disease is mainly caused due to mutation of CIAS1 gene, that leads to increased production of interleukin 1B. Globally, Extensive R&D activities, Technological advancement in research and genetic sciences and Growing concern about various genetic disorders are the prime growth drivers of global Near Infrared Imaging market. In addition, increase in adoption of Muckle-Wells Syndrome for newer applications, will create new opportunities for global Near Infrared Imaging market. However, higher cost of the research and development, lack of awareness and Low epidemiology are the key restraints for global Near Infrared Imaging market.

[researchreports2017-blog]

Geographically North America dominated global Muckle-Wells Syndrome market, and Asia Pacific is projected to have fastest growth, owing to extensive R&D activities, technological advancement in research and genetic sciences and growing concern about various genetic disorders. Extensive R&D is one of the major factor, propelling the market growth. Among all the family of cryopyrin, associated periodic syndromes (CAPS) have the highest market share in global Muckle-Wells Syndrome market. This report identifies the global Muckle-Wells Syndrome market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the potential growth opportunities in the coming years, while also reviewing the market drivers, restraints, growth indicators, challenges, market dynamics, competitive landscape, and other key aspects with respect to global Muckle-Wells Syndrome market.Muckle-Wells Syndrome (MWS) is a rare, genetic autosomal disease which leads to urticaria, sensorineural deafness, and also leads to amyloidosis. The disease is mainly caused due to mutation of CIAS1 gene, that leads to increased production of interleukin 1B. Globally, Extensive R&D activities, Technological advancement in research and genetic sciences and Growing concern about various genetic disorders are the prime growth drivers of global Near Infrared Imaging market. In addition, increase in adoption of Muckle-Wells Syndrome for newer applications, will create new opportunities for global Near Infrared Imaging market. However, higher cost of the research and development, lack of awareness and Low epidemiology are the key restraints for global Near Infrared Imaging market.

[researchreports2017-blog]

Muckle-Wells Syndrome (MWS) is a rare, genetic autosomal disease which leads to urticaria, sensorineural deafness, and also leads to amyloidosis. The disease is mainly caused due to mutation of CIAS1 gene, that leads to increased production of interleukin 1B. Globally, Extensive R&D activities, Technological advancement in research and genetic sciences and Growing concern about various genetic disorders are the prime growth drivers of global Near Infrared Imaging market. In addition, increase in adoption of Muckle-Wells Syndrome for newer applications, will create new opportunities for global Near Infrared Imaging market. However, higher cost of the research and development, lack of awareness and Low epidemiology are the key restraints for global Near Infrared Imaging market.

Geographically North America dominated global Muckle-Wells Syndrome market, and Asia Pacific is projected to have fastest growth, owing to extensive R&D activities, technological advancement in research and genetic sciences and growing concern about various genetic disorders. Extensive R&D is one of the major factor, propelling the market growth. Among all the family of cryopyrin, associated periodic syndromes (CAPS) have the highest market share in global Muckle-Wells Syndrome market. This report identifies the global Muckle-Wells Syndrome market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the potential growth opportunities in the coming years, while also reviewing the market drivers, restraints, growth indicators, challenges, market dynamics, competitive landscape, and other key aspects with respect to global Muckle-Wells Syndrome market.

[researchreports2017-blog]

Muckle-Wells Syndrome (MWS) is a rare, genetic autosomal disease which leads to urticaria, sensorineural deafness, and also leads to amyloidosis. The disease is mainly caused due to mutation of CIAS1 gene, that leads to increased production of interleukin 1B. Globally, Extensive R&D activities, Technological advancement in research and genetic sciences and Growing concern about various genetic disorders are the prime growth drivers of global Near Infrared Imaging market. In addition, increase in adoption of Muckle-Wells Syndrome for newer applications, will create new opportunities for global Near Infrared Imaging market. However, higher cost of the research and development, lack of awareness and Low epidemiology are the key restraints for global Near Infrared Imaging market.

Geographically North America dominated global Muckle-Wells Syndrome market, and Asia Pacific is projected to have fastest growth, owing to extensive R&D activities, technological advancement in research and genetic sciences and growing concern about various genetic disorders. Extensive R&D is one of the major factor, propelling the market growth. Among all the family of cryopyrin, associated periodic syndromes (CAPS) have the highest market share in global Muckle-Wells Syndrome market. This report identifies the global Muckle-Wells Syndrome market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the potential growth opportunities in the coming years, while also reviewing the market drivers, restraints, growth indicators, challenges, market dynamics, competitive landscape, and other key aspects with respect to global Muckle-Wells Syndrome market.